Georgia D. Montouris, MD
Clinical Professor
Boston University School of Medicine
Dept of Neurology

MD, Free University of Brussels




Georgia D. Montouris, MD, is a Clinical Professor of Neurology at the Boston University School of Medicine. She has held this position since 2009, when she was promoted from Assistant Professor. Dr. Montouris is also the Co-Director of Epilepsy Services of the Comprehensive Epilepsy Care Program for Children and Adults at Boston Medical Center. She has a long history as an instructor, starting at the Vanderbilt University School of Medicine in the Department of Neurology after she completed her residency there. In the field of neurology her specialty is epileptic research, specifically regarding the treatment of refractory epilepsy, investigational drug trials, and quality of life issues in patients with epilepsy

2011 Best Doctors Boston
2006-2007 Top Doctors Boston


A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety to Brivaracetam in subjects (>16 to 80 years old) with partial onset seizures
06/01/2011 - 05/31/2013 (PI)
UCB Biosciences Inc.


A Phase 3, open-label, multicenter, follow-up study to evaluate the long-term safety and efficacy of Protocol #1379
06/01/2011 - 05/31/2013 (PI)
UCB Biosciences Inc.


A Multi-Center, Open-Label, Long-Term, Follow-Up Study of the Safety and Efficacy of Levetiracetam in Children with Partial Onset Seizures
12/13/2004 - 12/12/2007 (PI)
UCB, Inc.


Trileptal Pregnancy Registry
07/01/2006 - 06/30/2007 (PI)
Minnesota Epilepsy Group, P.A.

An Open-Label Extension Trial to Determine Safety and Efficacy of Long-Term Oral SPM 927 in Patients with Partial Seizures
10/06/2004 - 01/31/2007 (PI)
Schwarz Biosciences, Inc.

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600 mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization
04/01/2004 - 03/30/2006 (PI)
Schwarz Biosciences, Inc.

A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation of Lamictal Extended-Release Adjunctive Therapy In Patients with Primary Generalized Tonic-Clonic Seizures
12/10/2004 - 12/09/2005 (PI)
GlaxoSmithKline, Inc.

A Double-Blind, Randomized, Multicenter, Placebo-Controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age from
10/13/2004 - 10/12/2005 (PI)
UCB Pharma, Inc.

A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation of Lamictal Extended-Release Adjunctive Therapy In Subjects With Partial Seizures
09/27/2004 - 09/26/2005 (PI)
GlaxoSmithKline, Inc.

An Open-Label Extension Trial to Determine Tolerability and Efficacy of Long-Term Oral SPM 927 as Adjunctive Therapy in Patients with Partial Seizures
11/01/2003 - 10/31/2004 (PI)
Schwarz Biosciences, Inc.

Showing 10 of 13 results. Show All Results

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray…
02/03/2016 - 02/28/2017 (PI)
Acorda Therapeutics, INC



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Scheuerle AE, Holmes LB, Albano JD, Badalamenti V, Battino D, Covington D, Harden C, Miller D, Montouris GD, Pantaleoni C, Thorp J, Tofighy A, Tomson T, Golembesky AK. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations. Birth Defects Res. 2019 May 23. PMID: 31124321.
     
  2. Vekeman F, Piña-Garza JE, Cheng WY, Tuttle E, Giguère-Duval P, Oganisian A, Damron J, Sheng Duh M, Shen V, Saurer TB, Montouris GD, Isojarvi J. Development of a classifier to identify patients with probable Lennox-Gastaut syndrome in health insurance claims databases via random forest methodology. Curr Med Res Opin. 2019 Mar 14; 1-6. PMID: 30870597.
     
  3. Reaven NL, Funk SE, Montouris GD, Saurer TB, Story TJ. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study. Epilepsy Behav. 2018 11; 88:66-73. PMID: 30241056.
     
  4. Nuss S, Camayd-Muñoz C, Jonas R, Wenger JK, Sewell K, Montouris G, Douglass L. Defining the Virtual Patient-Centered Medical Home. Clin Pediatr (Phila). 2018 Nov; 57(13):1592-1596.View Related Profiles. PMID: 30111172.
     
  5. Piña-Garza JE, Montouris GD, Vekeman F, Cheng WY, Tuttle E, Giguere-Duval P, Duh MS, Shen V, Saurer TB, Isojarvi J. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome. Epilepsy Behav. 2017 Aug; 73:46-50. PMID: 28609734.
     
  6. Gidal BE, Wechsler RT, Sankar R, Montouris GD, White HS, Cloyd JC, Kane MC, Peng G, Tworek DM, Shen V, Isojarvi J. Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study. Neurology. 2016 Oct 25; 87(17):1806-1812. PMID: 27683846.
     
  7. Piña-Garza JE, Chung S, Montouris GD, Radtke RA, Resnick T, Wechsler RT. Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature. Epilepsy Behav Case Rep. 2016; 5:38-43. PMID: 26977407; DOI: 10.1016/j.ebcr.2016.01.004;.
     
  8. Montouris G, Hohler AD. Cultural Barriers to Medication Adherence in Epilepsy. Continuum (Minneap Minn). 2016 Feb; 22(1 Epilepsy):266-9.View Related Profiles. PMID: 26844742; DOI: 10.1212/CON.0000000000000286;.
     
  9. Deck GM, Nadkarni N, Montouris GD, Lovett A. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010. Epilepsy Behav. 2015 Oct; 51:166-9. PMID: 26283306; DOI: 10.1016/j.yebeh.2015.07.001;.
     
  10. Montouris G, Yang H, Williams B, Zhou S, Laurenza A, Fain R. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel. Epilepsy Res. 2015 Aug; 114:131-40. PMID: 26088896; DOI: 10.1016/j.eplepsyres.2015.04.011;.
     
Showing 10 of 63 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 62 publications over 22 distinct years, with a maximum of 7 publications in 2004

YearPublications
19952
19961
19996
20006
20013
20021
20032
20047
20053
20074
20082
20091
20102
20113
20121
20134
20144
20152
20163
20171
20182
20192

Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
Contact for Mentoring:


75 E. Newton St Collamore Building
Boston MA 02118
Google Map


Montouris's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department